Nuvation Bio NUVB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.4M+110% | -$36.59M+26.0% | -$55.79M-35.4% | -$59.01M+87.2% | -$53.24M-260% | ||
| $536K+72.9% | $539K+146% | $534K+230% | $356K+45.9% | $310K+434% | ||
| $9.03M+15.0% | $7.99M-21.6% | $8.02M+7.3% | $12.03M+25.7% | $7.85M+55.8% | ||
| $321K— | $86K— | $213K— | $11K— | $0— | ||
| $6.65M+154% | $7.75M-38.5% | —— | —— | -$12.31M— | ||
| $12.96M+209% | —— | —— | $11.88M+494% | $4.19M+1,745% | ||
| -$12.32M-37.8% | $12.6M+72.0% | —— | —— | -$8.94M-692% | ||
| -$3.78M-2,509% | $145K-97.6% | $846K+243% | $0— | -$145K-130% | ||
| $4.44M+288% | $2.61M— | $669K-88.1% | $0— | $1.14M-78.3% | ||
| $5.07M+112% | -$29.73M+35.8% | -$52.89M-70.1% | -$48.18M-29.1% | -$42.63M-171% | ||
| $48K-33.3% | $0— | $7.75M+28,793% | $181K— | $72K+167% | ||
| -$43.64M-181% | $87.08M+68.2% | —— | $54.88M+60.1% | $54.18M+618% | ||
| $908K-16.1% | $7.71M+818% | $558K-66.6% | $762K-60.5% | $1.08M+5,052% | ||
| $0-100% | $11.2M+46.7% | $0-100% | $166K-97.4% | $534K— | ||
| $44K-92.0% | $8.06M— | $501K— | $193.42M+6,939% | $548K+2,510% | ||
| -$172K-214% | -$224K-120% | -$64K+91.4% | -$128K-264% | $151K— | ||
| -$38.7M-416% | $65.19M— | —— | $199.99M+88,986% | $12.25M+251% | ||
| —— | $720.5K+745% | $720.5K+745% | $720.5K+745% | $720.5K+745% | ||
| —— | $49.25K-47.2% | $49.25K-47.2% | $49.25K-47.2% | $49.25K-47.2% | ||
| $321K— | $86K— | $213K— | $11K— | $0— | ||
| $21K+108% | $670K— | $210K— | $453K— | -$248K— | ||
| $426K-81.5% | —— | $4.33M+808% | $2.2M+58.1% | $2.31M— | ||
| -$24K-102% | -$2.24M-294% | $1.54M+530% | -$1.07M-175% | $1.48M+155% | ||
| $4.43M+31,564% | $5.7M— | $5.16M— | $538K— | $14K— | ||
| $4.44M+288% | $2.61M— | $669K-88.1% | $0— | $1.14M-78.3% | ||
| -$5.08M— | -$5.02M— | -$4.86M— | -$266K— | $0— | ||
| -$66K-140% | —— | —— | $171K+538% | $164K+532% | ||
| $48K-33.3% | $89K— | $12K-91.9% | $181K— | $72K+167% | ||
| $864K— | —— | —— | -$150M— | $0— | ||
| -$2.87M-481% | $1.13M-1.6% | -$612K-14.8% | -$454K+60.0% | $751K-48.5% | ||
| $109K-97.0% | —— | $99K-53.5% | $87K— | $3.69M— | ||
| —— | $967.75K+524% | $967.75K+524% | $967.75K+524% | $967.75K+524% | ||
| $5.02M+112% | -$29.73M+35.8% | -$60.64M-95.2% | -$48.36M-29.6% | -$42.7M-171% | ||
| $5.02M+112% | -$29.73M+35.8% | -$60.64M-95.2% | -$48.36M-29.6% | -$42.7M-171% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Nuvation Bio's cash flow data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.